Stock Scorer

SkinHealth Systems Inc. (SKIN)

SkinHealth Systems Inc. reported revenue of 72.1M USD for the quarter ending 30 June 2026, down 7.8% from 78.2M a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 30 June 2026 72.1M -7.8%
Gross Profit Q2 '26 · ending 30 June 2026 49.3M +0.5%
Operating Income Q2 '26 · ending 30 June 2026 3.6M —
Net Income Q2 '26 · ending 30 June 2026 -2.7M -113.5%
Cost of Revenue Q2 '26 · ending 30 June 2026 22.8M -21.7%
Operating Cash Flow Q2 '26 · ending 30 June 2026 2.7M -72.3%
Free Cash Flow Q2 '26 · ending 30 June 2026 2.2M -76.5%
Shares Outstanding Q2 '26 · ending 30 June 2026 129.6M +3.6%
EPS Q2 '26 · ending 30 June 2026 -0.21 —

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 300.8M-20.8M-9.5M37.2M
20242024-12-31 334.3M-67.8M-29.1M15.4M
20232023-12-31 398M-130.9M-100.1M17.9M
20222022-12-31 365.9M-25.8M44.2M-117.4M
20212021-12-31 260.1M-39.9M-378.8M-39.6M
20202020-12-31 119.1M-17.2M-29.2M-15.9M
20192019-12-31 166.6M13.5M-1.6M-7M

Every period

Revenue Quarterly

PeriodEndingRevenue
Q2 '262026-06-3072.1M
Q1 '262026-03-3164.9M
Q4 '252025-12-3182.4M
Q3 '252025-09-3070.7M
Q2 '252025-06-3078.2M
Q1 '252025-03-3169.6M
Q4 '242024-12-3183.5M
Q3 '242024-09-3078.8M
Q2 '242024-06-3090.6M
Q1 '242024-03-3181.4M
Q4 '232023-12-3196.8M
Q3 '232023-09-3097.4M
Q2 '232023-06-30117.5M
Q1 '232023-03-3186.3M
Q4 '222022-12-3198.1M
Q3 '222022-09-3088.8M
Q2 '222022-06-30103.5M
Q1 '222022-03-3175.4M
Q4 '212021-12-3177.9M
Q3 '212021-09-3068.1M

Gross Profit Quarterly

PeriodEndingGross Profit
Q2 '262026-06-3049.3M
Q1 '262026-03-3144.4M
Q4 '252025-12-3153M
Q3 '252025-09-3045.6M
Q2 '252025-06-3049.1M
Q1 '252025-03-3148.6M
Q4 '242024-12-3152.3M
Q3 '242024-09-3040.6M
Q2 '242024-06-3040.9M
Q1 '242024-03-3148.4M
Q4 '232023-12-3145.7M
Q3 '232023-09-30-12.6M
Q2 '232023-06-3067.9M
Q1 '232023-03-3154.1M
Q4 '222022-12-3166.5M
Q3 '222022-09-3061.4M
Q2 '222022-06-3070M
Q1 '222022-03-3150.9M
Q4 '212021-12-3153.5M
Q3 '212021-09-3046.1M

Operating Income Quarterly

PeriodEndingOperating Income
Q2 '262026-06-303.6M
Q1 '262026-03-31-1.8M
Q4 '252025-12-31162K
Q3 '252025-09-30-6.2M
Q2 '252025-06-30-2.7M
Q1 '252025-03-31-12M
Q4 '242024-12-31-7.2M
Q3 '242024-09-30-21.5M
Q2 '242024-06-30-22.1M
Q1 '242024-03-31-17M
Q4 '232023-12-31-18.4M
Q3 '232023-09-30-82.1M
Q2 '232023-06-30-13.1M
Q1 '232023-03-31-17.3M
Q4 '222022-12-31-2.4M
Q3 '222022-09-30-4.4M
Q2 '222022-06-30-5M
Q1 '222022-03-31-14M
Q4 '212021-12-31-10.5M
Q3 '212021-09-30-5.5M

Net Income Quarterly

PeriodEndingNet Income
Q2 '262026-06-30-2.7M
Q1 '262026-03-31-6.6M
Q4 '252025-12-31-8.1M
Q3 '252025-09-30-11M
Q2 '252025-06-3019.7M
Q1 '252025-03-31-10.1M
Q4 '242024-12-31-10.3M
Q3 '242024-09-30-18.3M
Q2 '242024-06-30202K
Q1 '242024-03-31-679K
Q4 '232023-12-31-9.4M
Q3 '232023-09-30-73.8M
Q2 '232023-06-303.4M
Q1 '232023-03-31-20.3M
Q4 '222022-12-316.5M
Q3 '222022-09-30-81K
Q2 '222022-06-306.3M
Q1 '222022-03-3131.5M
Q4 '212021-12-31-21M
Q3 '212021-09-30-215.1M

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q2 '262026-06-3022.8M
Q1 '262026-03-3120.5M
Q4 '252025-12-3129.3M
Q3 '252025-09-3025M
Q2 '252025-06-3029.1M
Q1 '252025-03-3121M
Q4 '242024-12-3131.1M
Q3 '242024-09-3038.2M
Q2 '242024-06-3049.7M
Q1 '242024-03-3133M
Q4 '232023-12-3151.1M
Q3 '232023-09-30110M
Q2 '232023-06-3049.6M
Q1 '232023-03-3132.2M
Q4 '222022-12-3131.6M
Q3 '222022-09-3027.4M
Q2 '222022-06-3033.5M
Q1 '222022-03-3124.5M
Q4 '212021-12-3124.4M
Q3 '212021-09-3022.1M

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262026-06-302.7M
Q1 '262026-03-31-5.6M
Q4 '252025-12-3115.2M
Q3 '252025-09-309.6M
Q2 '252025-06-309.6M
Q1 '252025-03-313M
Q4 '242024-12-3116.5M
Q3 '242024-09-3010.3M
Q2 '242024-06-306.2M
Q1 '242024-03-31-16.9M
Q4 '232023-12-31-5.2M
Q3 '232023-09-3018M
Q2 '232023-06-3022M
Q1 '232023-03-31-13M
Q4 '222022-12-31-5.4M
Q3 '222022-09-30-31.4M
Q2 '222022-06-30-31.3M
Q1 '222022-03-31-38.5M
Q4 '212021-12-313.3M
Q3 '212021-09-30298K

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q2 '262026-06-302.2M
Q1 '262026-03-31-5.8M
Q4 '252025-12-3115.1M
Q3 '252025-09-309.6M
Q2 '252025-06-309.6M
Q1 '252025-03-313M
Q4 '242024-12-3116.4M
Q3 '242024-09-3010.3M
Q2 '242024-06-305.9M
Q1 '242024-03-31-17.2M
Q4 '232023-12-31-5.2M
Q3 '232023-09-3017.8M
Q2 '232023-06-3020.7M
Q1 '232023-03-31-15.3M
Q4 '222022-12-31-6.4M
Q3 '222022-09-30-35.7M
Q2 '222022-06-30-33.8M
Q1 '222022-03-31-41.6M
Q4 '212021-12-31-3.1M
Q3 '212021-09-30148K

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q2 '262026-06-30129.6M
Q1 '262026-03-31131.4M
Q3 '252025-09-30126.9M
Q2 '252025-06-30140.3M
Q1 '252025-03-31125.1M
Q3 '242024-09-30124.1M
Q2 '242024-06-30141.9M
Q1 '242024-03-31144.5M
Q3 '232023-09-30132.9M
Q2 '232023-06-30132.7M
Q1 '232023-03-31132.4M
Q3 '222022-09-30151.4M
Q2 '222022-06-30151.7M
Q1 '222022-03-31152.7M
Q3 '212021-09-30132.3M
Q2 '212021-06-3091.8M
Q1 '212021-03-3135.5M
Q3 '202020-09-3035.4M
Q2 '202020-06-3034.5M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q2 '262026-06-30-0.21
Q4 '232023-12-31-0.76
Q3 '232023-09-30-0.69
Q2 '222022-06-30-2.29
Q1 '222022-03-31-3.75
Q4 '212021-12-31-3.71
Q3 '212021-09-30-3.45
Q2 '212021-06-30-1.82